mRNA疫苗联合疗法显著改善黑色素瘤，Moderna与默克股价大涨

THERE YOU CANCER VACCINE THAT COULD PREVENT MELANOMA FROM VACCINE THAT COUOULD PREVENT MELANOMA FROM RETURNING IN PATIENTS. PREVENT MELANOMA FROM RETURNING IN PATIENTS. THE RETURNS SO RETURNING IN PATIENTS. THTHE RETURNS SO PROMISING THEY SENT THE RETURNS SO PROMISING THEY S SENT STOCKS SOARING TODAY. PROMISING THEY SENT STOCKS SOARING TODAY.

Reporter: A STOCKS SOARING TODAY.

Reporter: A POTENTIAL PIVOTAL

Reporter: A POTENTIAL PIPIVOTAL MOMENT IN THE FIGHT POTENTIAL PIVOTAL MOMENT IN THE FIGHT AGAINST HIGH-RISK MOMENT IN THE FIGHT AGAINST HIGH-RISK MELANOMA. AGAINST HIGH-RISK MELANOMA. AN MRNA VACCINE MELANOMA. AN MRNA VACCINE COMBINED WITH KITRUDA AN MRNA VACCINE COMBINED WITH KITRUDA SHOWING IMPROVEMENTS. COMBINED WITH KITRUDA SHOWING IMPROVEMENTS. MELANOMA KILLS MORE SHOWING IMPROVEMENTS. MELANOMA KILLS MORE THAN 8,000 PEOPLE A MELANOMA KILLS MORE THAN 8,000 PEOPLE A YEAR.

THAN 8,000 PEOPLE E A YEAR. THIS DOCTOR WORKED ON THIS DOCTOR WORKED ON THE TRIAL.

O OTHER TYPES OF THE TRIAL.

OTHER TYPES OF CANCER VACCINES IN

OTHER TYPES OF CANCER VACCINES IN GENERAL HAVE BEEN CANCER VACCINES IN GENERAL HAVE BEEN APPROVED, THIS IS THE GENERAL HAVEVE BEEN APPROVED, THIS IS THE FIRST PERSONALIZED APPROVED, THIS IS THE FIRST PERSONALIZED VACCINE THAT'S SHOWN A FIRST PERSONALIZED VACCINE THAT'S SHOWN A BENEFIT IN A PHASE VACCINE THAT'S SHOWN A BENEFIFIT IN A PHASE THREE STUDY SO FAR. BENEFIT IN A PHASE THREE STUDY SO FAR.

Reporter: HE GOT THREE STUDY SO FAR.

Reporter:r: HE GOT THE VACCINE AFTER A

Reporter: HE GOT THE VACCINE AFTER A DIFFICULT DIAGNOSISIS. THE VACCINE AFTER A DIFFICULT DIAGNOSIS.S.

NOT VERY GOOD, 70% DIFFICULT DIAGNOSIS.

NOT VERY GOOD, 70% CHANCE IF I REMEMBER

NOT VERY GOOD, 70% CHANCE IF I REMEMBER CORRECTLY OF THE CHANCE IF I REMEMBER CORRECTLY OF THE MELANOMA RETURNING IN CORRECTLY OF THE MELANOMA RETURNING IN A FIVE-YEAR PERIOD OF MELANOMA RETURNING IN A FIVE-YEAR PERIOD OF TIME. A FIVE-YEAR PERIRIOD OF TIME. NOW THE SCHOOL TEACHER TIME. NOW THE SCHOOL TEACHER SAYS HE'S S CANCER FREE. NOW THE SCHOOL TEACHER SAYS HE'S CANCER F FREE.

HAPPY AND HEALTHY. SAYS HE'S CANCER FREE.

HAPPY AND HEALTHY.

R Reporter: FIRST

HAPPY AND HEALTHY.

Reporter: FIRSTST DOCTORS SURGICALLY

Reporter: FIRST DOCTORS SURGICALLY REMOVE THE TUMOR. DOCTORS SURGICALLY REMOVE THE TUMOR. THE PATIENT STARTS ON REMOVE THE TUMOR. THE PATIENT STARTS ON THE MEDICINE WHILE THE THE PATIENT STARTS ON THE MEDICINE WHILE THE BLOOD IS ANALYZED TO THE MEDICINE WHILE THE BLOOD IS ANALYZED TO MAKE A VACCINE. BLOOD IS ANALYZED TO MAKEKE A VACCINE. IT TAKES ABOUT SIX MAKE A VACCINE. IT TAKES ABOUT SIX WEEKS. IT TAKES ABOUT SIX WEEKS.

MODERN WEEKS. MODERN MODERNA AND MERCK SAW MODERNRN MODERNA AND MERCK SAW THEIR STOCK PRICES MODERNA A AND MERCK SAW THEIR STOCK PRICES JUMP FROM THE NEWS. JUMP FROM THE NEWS. MORE SPECIFICS ON THE TRIAIAL OUTCOMES ARE MORE SPECIFICS ON THE TRIAL OUTCOMES ARE EXPECTED LATER THIS TRIAL OUTCOMES ARE EXPECTE